RETRACTED: Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder - Concepedia

Concepedia

Publication | Open Access

RETRACTED: Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

DOI Full Paper Access

17

Citations

38

References

2021

Year

Mahmoud S. Abdallah, Ahmed Nabil Ramadan, Hend Omara‐Reda, Noha O. Mansour, Mohamed Ahmed Elsokary, Hozaifa Elsawah, Shimaa Abdelsattar Zaki, Hend E. Abo Mansour, Esraa M. Mosalam

CNS Neuroscience & Therapeutics

Abstract

CLS is safe and effective short-term adjunctive therapy in patients with MDD with no other comorbid conditions. Trial registration ID:NCT04069819.

References

	Year	Citations

Page 1